Building the infrastructure layerfor tech-enabled drug discovery
We are the only biotechnology company advancing small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation.
We integrate AI with three proprietary data streams – computational data, wet lab proxy biological data, and wet lab ground truth biological data – to deliver novel drug candidates and software solutions to leading pharma and tech partners, and advance our internal pipeline for neurological, autoimmune diseases, and cancer.
Want more insights? Check out our posts.
Have a lookAccenture Collaborates with 1910 Genetics to Help Biopharma Companies Transform Drug Discovery with AI
4m read 31st October, 2024.
1910 Genetics Launches CANDID-CNS™, an AI Model for Blood-Brain Barrier Permeability Prediction that Outperforms the Industry Standard
5m read 17th October, 2024.
Microsoft partners with Boston biotech to build 'drug discovery on steroids'
3m read 29th April, 2024.